- Rapid Flu Tests: $30
- Rapid Covid-19 Tests: $30
- Rapid Strep Tests: $15
- Covid-19/ Flu/ Strep combo $50
All Results are available in 15mins or less
Covid-19 Report available for Travels.
PCR testing available with results in 24 hours.
Schedule your appointment at
http://medioak-pharmacy-105776.square.site/
COVID-19/Flu /Strep Treatments and Medications available at MediOAK Pharmacy
For people who are more likely to get very sick from COVID-19 infection, medications are available that can reduce your chances of severe illness and death. Other medications can help reduce symptoms and help you manage your illness.
Here’s what you need to know.
Treating COVID-19
If you test positive and are more likely to get very sick from COVID-19, treatments are available that can reduce your chances of being hospitalized or dying from the disease. Medications to treat COVID-19 must be prescribed by a healthcare provider and started as soon as possible after diagnosis to be effective. Contact a healthcare provider right away to determine if you are eligible for treatment, even if your symptoms are mild right now.
Don’t delay: Treatment must be started within days after you first develop symptoms to be effective.
People who are more likely to get very sick include older adults (ages 50 years or more, with risk increasing with older age), people who are unvaccinated, and people with certain medical conditions, such as a weakened immune system. Being vaccinated makes you much less likely to get very sick. Still, some vaccinated people, especially those ages 65 years or older or who have other risk factors for severe disease, may benefit from treatment if they get COVID-19. A healthcare provider will help decide which treatment, if any, is right for you.
The FDA has issued emergency use authorizations (EUA) for certain antiviral medications and monoclonal antibodies to treat mild to moderate COVID-19 in people who are more likely to get very sick.
- Antiviral treatments target specific parts of the virus to stop it from multiplying in the body, helping to prevent severe illness and death.
- Monoclonal antibodies help the immune system recognize and respond more effectively to the virus. They may be more or less effective against different variants of the virus that causes COVID-19.
The National Institutes of Health (NIH) provides COVID-19 Treatment Guidelines for healthcare providers to help them work with their patients and determine the best treatment options for them. Several options are available for treating COVID-19 at home or in an outpatient setting. They include:
- Nirmatrelvir with ritonavir (Paxlovid) is an investigational antiviral treatment used in adults and children ages 12 years and older. It is taken at home by mouth (orally). It should be started as soon as possible and must begin within 5 days of when your symptoms start.
- Remdesivir (Veklury) is an antiviral treatment used in adults and children. Treatment requires intravenous (IV) infusions at a healthcare facility for 3 consecutive days. It should be started as soon as possible and must begin within 7 days of when your symptoms start.
- Bebtelovimab is an investigational monoclonal antibody treatment used in adults and children ages 12 years and older. A healthcare provider gives bebtelovimab as a single IV injection. It should be started as soon as possible and must begin within 7 days of when your symptoms start.
- Molnupiravir (Lagevrio) is an investigational antiviral treatment used in adults ages 18 years and older. It is taken at home by mouth (orally). It should be started as soon as possible and must begin within 5 days of when your symptoms start.
Some treatments might have side effects or interact with other medications you are taking.
If you want us to call you, please use form below.